The results demonstrated that in hypoxic pancreatic cancer cells, curcumin downregulates Beclin1 expression and inhibits HIF-1α-mediated glycolysis, thereby inhibiting pancreatic cancer cell proliferation. The gene discussed is HIF1A; the disease is familial pancreatic carcinoma.